Pathogen inactivation: making decisions about new technologies

Harvey G. Klein(St. Michael's Hospital), David R. Anderson(St. Michael's Hospital), Marie‐Josée Bernardi(National Institutes of Health), Ritchard G. Cable(Queen's University), William Carey(American Red Cross), Jeffrey S. Hoch(Centre Hospitalier de l’Université de Montréal), Nancy Robitaille(St. Michael's Hospital), Marco L.A. Sivilotti(Queen Elizabeth II Health Sciences Centre), Fiona Smaill(Centre Hospitalier de l’Université de Montréal)

Transfusion

November 21, 2007

10.1111/j.1537-2995.2007.01512.x

Cited by 104

Abstract

Related Papers

Cost-Effectiveness in Health and Medicine

|Unknown|1996|7.1k

Laws of fear: beyond the precautionary principle

|Choice Reviews Online|2006|581

Current Risks of Transfusion-Transmitted Agents: A Review

Susan L. Stramer|Archives of Pathology & Laboratory Medicine|2007|162

Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services

Sheila F. O’Brien, Qilong Yi, Wenli Fan et al.|Transfusion|2007|153

HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study.

Barbara L. Kroner, Philip S. Rosenberg, Louis M. Aledort et al.|PubMed|1994|123